Skip to content

Drug interactions

Eliglustat + Temsirolimus

Severity: Minor

Eliglustat and Temsirolimus: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eliglustat inhibits P-glycoprotein and could increase temsirolimus exposure. The effect is likely small given that temsirolimus is given intravenously and cleared mainly by CYP3A4.

What this interaction means in plain words

Eliglustat and Temsirolimus have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Eliglustat belongs to Miscellaneous; Temsirolimus belongs to Oncology.

Evidence level: Low

Why it happens

Eliglustat inhibits P-gp, potentially reducing efflux of temsirolimus.

What to do

No empirical dose change is needed; monitor for temsirolimus toxicity and reduce the dose if adverse effects emerge.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eliglustat and Temsirolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Eliglustat with Temsirolimus?

MediHelp rates the interaction as minor. Eliglustat and Temsirolimus have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Eliglustat inhibits P-glycoprotein and could increase temsirolimus exposure. The effect is likely small given that temsirolimus is given intravenously and cleared mainly by CYP3A4.

How serious is the interaction between Eliglustat and Temsirolimus?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empirical dose change is needed; monitor for temsirolimus toxicity and reduce the dose if adverse effects emerge.

What other medicines interact with Temsirolimus?

MediHelp also lists interactions of Temsirolimus with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine live. The full list is on the Temsirolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in